Rebecca Voelker
Abstract
The novel antiepileptic medication cenobamate has received approval for adults who have partial-onset seizures. The drug offers a new alternative for the more than one-third of patients with epilepsy whose seizures aren’t controlled despite treatment with 1 or more antiepileptic drugs.
OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The novel antiepileptic medication cenobamate has received approval for adults who have partial-onset seizures. The drug offers a new alternative for the more than one-third of patients with epilepsy whose seizures aren’t controlled despite treatment with 1 or more antiepileptic drugs.
Key concepts: Medicine, partial seizures, Partial epilepsy, Antiepileptic drug, Epilepsy, Complex partial seizures, Pediatrics, Psychiatry